Vermiscab-A  -  Susp	Ivermectine ...............6mg. Albendazole ............. 400 mg.
Vermiscab-A  -  Susp	Ivermectine .......... 3mg. Albendazole ..............400 mg.

IVERMECTIN
Ivermectin is US-FDA approved and also WHO approved Single Dose Therapy for Scabies, Pediculosis and Intestinal Nematodes. 

PHARMACOKINETICS

Following oral administration, peak plasma concentrations of 46 ng / ml are achieved in 4 hours.  Ivermectin is absorbed well which gives bioavailability around 50% to 60%.  Ivermectin and its metabolites are excreted mainly in feces (99%) over an estimated period of 12 Days with less than 1% of dose excreted in urine.  Ivermectin is well tolerated and has no CNS toxicity.

DRUG INTERACTON: Nil

ALBENDAZOLE

Albendazole is well established.  It is well tolerated and is highly useful in intestinal nematodes as single dose oral therapy.

IVERMECTIN PLUS ALBENDAZOLE PHARMACODYNAMICSBoth are trusted molecules having synergistic efficacy.  Both cover Ectoparasites and Ednoparasites.  Both have coverage of complete life cycle of parasites as both are OVICIDAL, LARVICIDAL and WORMICIDAL.

In all aspects, Albendazole and Ivermectin are drugs of choice for PEDICULOSIS, CRUSTED SCABIES and MIXED INTESTINAL HELMINTHS INFESTATIONS.  Both are particularly useful in severely crusted scabies lesions, in immunocompromised patients and when topical therapy has failed.  Oral dosing of the combination is more convenient especially in institutional outbreaks.

VERMISCAB-A DOSAGE

We are sure, above information is adequate and can be fruitfully used by you.  If the need be, a photocopy of the above details can be handed over to any customer in your territory.